9
Apr
2025
Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
Exhibitor at CPHI Japan 2025 stand 5S-13
About Us
-
CN -
2015On CPHI since
Company types
Event information
CPHI Japan 2025
-
09 Apr 2025 – 11 Apr 2025
-
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
-
Visit us at stand 5S-13
Products Featured at CPHI Japan 2025
-
Product 3-Aminopyrrolidine dihydrochloride
Prompt delivery -
Product 9-(4-acetoxy-3-acetoxymethylbut-1-yl)-2-amino-6-chloropurine
Key intermediate for Famciclovir -
Product Aztreonam
In-house specification -
Product CANDESARTAN CILEXETIL
Chinese GMP was approved, Has Chinese patent. -
Product DROXIDOPA
JP specification -
Product Duloxetine HCl
competitve price and good quality -
Product FAMCICLOVIR
US FDA approved product, competive price can be offer. -
Product IBANDRONATE SODIUM
US FDA approved. -
Product Lercanidipine HCl
Any question, please contact with us. -
Product Pilsicainide Hydrochloride
For Japanese market -
Product Pranlukast hydrate
As COA -
Product TOSUFLOXACIN TOSYLATE
High quality , exported to Japan. -
Product ZIPRASIDONE HCL
For details, please contact with me.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance